Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.334, 2001-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Neonatal group B streptococcal sepsis: prevention worthwhile?
Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. :
Access to resources
Recommend
Antibacterials can reduce the incidence of neonatal early-onset group B streptococcal sepsis
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
Neonatal Sepsis: Epidemiology and Management
Pediatric Drugs, Vol. 5, Iss. 11, 2003-01 ,pp. :
Preventing group B streptococcal disease: which strategy best?
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :
Current best practice for neonatal strep B prevention not ideal
Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. :